Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

473
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
473
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

59
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
59
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

190
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
190
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

93
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
93
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

47
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
47
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

58
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
58

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Planning for the forgotten fourth trimester of pregnancy: A parallel group randomized control trial to test a postpartum planning intervention vs. standard prenatal care.

Contemporary clinical trials·2024
Same author

Chronic Stress and Preconception Health Among Latina Women in Metro Atlanta.

Maternal and child health journal·2021
Same author

The Historical, Psychosocial, and Cultural Context of Breastfeeding in the African American Community.

Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine·2021
Same author

Implementation of a Postpartum Hemorrhage Safety Bundle at an Urban Safety-Net Hospital.

AJP reports·2020
Same author

Executive Summary and Call to Action: Maternal Mortality Summit at National Medical Association Meeting, July 28, 2019 in Honolulu, Hawaii Obstetrics and Gynecology Section of the National Medical Association.

Journal of the National Medical Association·2020
Same author

The influence of lack of reference conditions on dosimetry in pre-clinical radiotherapy with medium energy x-ray beams.

Physics in medicine and biology·2020

Related Experiment Video

Updated: Oct 3, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.5K

Breast Cancer Risk Assessment and Management of the High-Risk Patient.

Victoria L Green1

  • 1Department of Gynecology and Obstetrics, Emory University, Glenn Building 4th Floor, Atlanta, GA 30303, USA; Gynecology Comprehensive Breast Center, Winship Cancer Institute at Grady Memorial Hospital; Avon Breast Center.

Obstetrics and Gynecology Clinics of North America
|February 16, 2022
PubMed
Summary

Identifying high-risk women is key to reducing breast cancer burden. Risk assessment and shared decision-making guide interventions like genetic testing and enhanced surveillance for optimal patient benefit.

Keywords:
Breast cancerBreast cancer risk assessmentBreastfeedingGenetic testingHigh-risk breast diseasePharmacologic preventionRisk assessment modelsRisk reduction strategies

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.4K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

405

Related Experiment Videos

Last Updated: Oct 3, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.5K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.4K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

405

Area of Science:

  • Oncology
  • Preventive Medicine
  • Genetics

Background:

  • Breast cancer is the most common non-skin cancer in women.
  • Guidelines recommend interventions for women at highest risk to reduce disease burden and unnecessary treatments.

Purpose of the Study:

  • To emphasize the importance of risk assessment in identifying women who benefit most from breast cancer interventions.
  • To highlight the role of shared decision-making in implementing risk reduction strategies.

Main Methods:

  • Utilizing breast cancer risk factors and established risk assessment models.
  • Incorporating patient values, goals, and objectives into clinical decisions.

Main Results:

  • Risk assessment is crucial for identifying women who will benefit from risk reduction strategies.
  • Shared decision-making principles are essential for guiding interventions.

Conclusions:

  • Accurate risk assessment is paramount for effective breast cancer prevention and management.
  • Shared decision-making ensures that interventions align with individual patient needs and preferences.